Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asanao Shimokawa

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The International Journal of Biostatistics|February 15, 2017
On Stratified Adjusted Tests by Binomial TrialsAsanao Shimokawa, Etsuo Miyaoka
Journal of Biopharmaceutical Statistics|July 21, 2020
Construction of a survival tree for dependent censoringAsanao Shimokawa, Etsuo Miyaoka
The International Journal of Biostatistics|July 29, 2024
Detecting differentially expressed genes from RNA-seq data using fuzzy clusteringYuki Ando, Asanao Shimokawa
The International Journal of Biostatistics|April 8, 2015
Comparison of splitting methods on survival treeAsanao Shimokawa, Yohei Kawasaki, Etsuo Miyaoka
Journal of Biopharmaceutical Statistics|June 5, 2015
A comparative study on splitting criteria of a survival tree based on the Cox proportional modelAsanao Shimokawa, Yohei Kawasaki, Etsuo Miyaoka
The International Journal of Biostatistics|February 17, 2016
Tree Based Method for Aggregate Survival Data ModelingAsanao Shimokawa, Yoshitaka Narita, Soichiro Shibui, et al.
Journal of Biopharmaceutical Statistics|September 1, 2015
A Bayesian equivalency test for two independent binomial proportionsYohei Kawasaki, Asanao Shimokawa, Hiroshi Yamada, et al.
JTO Clinical and Research Reports|October 24, 2022
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance DataHideki Terai, Kenzo Soejima, Asanao Shimokawa, et al.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The International Journal of Biostatistics|February 15, 2017
On Stratified Adjusted Tests by Binomial TrialsAsanao Shimokawa, Etsuo Miyaoka
Journal of Biopharmaceutical Statistics|July 21, 2020
Construction of a survival tree for dependent censoringAsanao Shimokawa, Etsuo Miyaoka
The International Journal of Biostatistics|July 29, 2024
Detecting differentially expressed genes from RNA-seq data using fuzzy clusteringYuki Ando, Asanao Shimokawa
The International Journal of Biostatistics|April 8, 2015
Comparison of splitting methods on survival treeAsanao Shimokawa, Yohei Kawasaki, Etsuo Miyaoka
Journal of Biopharmaceutical Statistics|June 5, 2015
A comparative study on splitting criteria of a survival tree based on the Cox proportional modelAsanao Shimokawa, Yohei Kawasaki, Etsuo Miyaoka
The International Journal of Biostatistics|February 17, 2016
Tree Based Method for Aggregate Survival Data ModelingAsanao Shimokawa, Yoshitaka Narita, Soichiro Shibui, et al.
Journal of Biopharmaceutical Statistics|September 1, 2015
A Bayesian equivalency test for two independent binomial proportionsYohei Kawasaki, Asanao Shimokawa, Hiroshi Yamada, et al.
JTO Clinical and Research Reports|October 24, 2022
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance DataHideki Terai, Kenzo Soejima, Asanao Shimokawa, et al.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Pageof 1